Abstract
Results indicate that all levels of migraine pain are associated with significantly reduced utility values. As severity worsened, utility decreased and severe migraine pain was considered a health state worse than death. Results can be used in cost-utility models examining the relative economic value of therapeutic strategies for migraine in the UK.
Introduction
Migraine is a debilitating episodic condition, yet its "invisible" and temporary nature often obscures its true impact in health economic assessments. To determine the value of new treatments, organizations like the UK’s National Institute for Health and Care Excellence (NICE) rely on Quality-Adjusted Life Years (QALYs), which require precise "utility values" for specific health states. Historically, there has been a lack of UK-specific data mapping migraine severity levels (mild, moderate, severe) to the standard EQ-5D utility scale. This study addresses this gap by eliciting these values directly from a UK sample of migraineurs.
Methods
This cross-sectional, observational study recruited 106 UK-based migraineurs through support group networks. Participants were required to be at least 18 years old, have a 6-month history of physician-diagnosed migraines, and have experienced an attack within the previous seven days.
The researchers employed the EQ-5D instrument, which evaluates mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Due to the difficulty of surveying patients during acute attacks, a retrospective recall method was used. Participants utilized "clock props" and calendars to map out their most recent attack and completed the EQ-5D for four states: current health (outside of an attack), and health during mild, moderate, and severe pain levels. Responses were converted into utility indices using the York preference tariff.
Results
The study sample was 76.4% female with a mean age of 47.4 years. The analysis revealed a clear, statistically significant decline in utility as pain severity increased.
As shown in the table above, the mean utility for "current health" (inter-ictal state) was 0.87, significantly lower than perfect health (1.0). Utility dropped to 0.66 for mild pain and 0.53 for moderate pain. Most notably, severe migraine pain resulted in a mean utility of -0.20.
The box plot illustrates the distribution of these scores. The negative utility for severe migraine indicates a state considered "worse than death" by health economic standards. All differences between severity levels were statistically significant (p < 0.0001). Additionally, a significant negative correlation (-0.29) was found between current health utility and the Migraine Disability Assessment (MIDAS) score, indicating that higher overall disability correlates with lower quality of life even between attacks.
Discussion
The findings highlight the extreme burden of migraine. The drop in utility from a non-migraine state to severe migraine (a decrement of 1.07) exceeds that seen in many chronic conditions, such as rheumatoid arthritis. Furthermore, the "inter-ictal" utility of 0.87 suggests a baseline reduction in quality of life even between attacks, likely due to anticipatory anxiety or sub-clinical symptoms.
While the study is limited by its reliance on retrospective recall and potential convenience sampling from support groups, it provides essential data for UK cost-utility models. These values allow for more accurate evaluations of the economic value of both acute and preventative migraine therapies. Future research should explore the utility impacts of the prodrome and postdrome phases to further refine these economic models.
Summary updated